Does restaging transurethral resection of bladder tumor influence outcomes in patients treated with BCG immunotherapy? 491 cases in 20 years’ experience
Main Authors: | Wojciech Krajewski, Romuald Zdrojowy, Katarzyna Kościelska-Kasprzak, Janusz Dembowski, Michał Wróbel, Mateusz Łuczak, Anna Kołodziej |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2018-12-01
|
Series: | Videosurgery and Other Miniinvasive Techniques |
Subjects: | |
Online Access: | https://www.termedia.pl/Does-restaging-transurethral-resection-of-bladder-tumor-influence-outcomes-in-patients-treated-with-BCG-immunotherapy-491-cases-in-20-years-experience,42,34273,1,1.html |
Similar Items
-
Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit
by: Wojciech Krajewski, et al.
Published: (2020-10-01) -
Genetic and immunologic determinants of intravesical BCG therapy in non-muscle-invasive urothelial bladder cancer
by: Wojciech Krajewski, et al.
Published: (2014-03-01) -
Genetic and immunologic determinants of intravesical BCG therapy in non-muscle-invasive urothelial bladder cancer
by: Wojciech Krajewski, et al.
Published: (2014-03-01) -
Miliary Tuberculosis Due to BCG Immunotherapy
by: Bilgehan AYGEN, et al.
Published: (1996-03-01) -
Utility of restage transurethral resection of bladder tumor
by: Vignesh Manoharan, et al.
Published: (2018-01-01)